Medtronic has recalled more than 204,000 devices used to assist hospital and other patients with end-stage heart failure due to the potential for power source interruptions, the Food and Drug Administration reported Friday. The HeartWare Ventricular Assist Device is used as a bridge to cardiac transplantation in patients who are at risk of death from end-stage left ventricular heart failure. Health care professionals and consumers may report adverse reactions and quality problems with the devices to the FDA’s MedWatch program. For more information, see the recent Medtronic letter to health care providers.

Related News Articles

Headline
A new study published in JAMA Internal Medicine is confirming the role Medicare plays in decreasing disparities in health care access and coverage in the…
Headline
By integrating behavioral health into physical care and tapping into community partnerships, hospitals and health systems can develop culturally competent…
Headline
Yale New Haven Health will receive the 2021 AHA Quest for Quality Prize this week at AHA’s annual Leadership Summit for its deep commitment to improving the…
Chairperson's File
AHA’s Institute for Diversity and Health Equity has been working for more than 25 years to advance health equity, diversity and inclusion by supporting…
Blog
There’s no turning away from the physical and emotional suffering caused by the COVID-19 pandemic. We’ve experienced every type of upheaval — in some cases…
News
Reps. Peter Welch, D-Vt., Suzan DelBene, D-Wash., Darin LaHood, R-Ill., and Brad Wenstrup, R-Ohio, yesterday reintroduced the Value in Health Care Act, AHA-…